ReviewDegenerative neurological and neuromuscular disease2017

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis.

Michael Hinchcliffe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.